SCHEMBL30449840

SCHEMBL30449840

COc1ccc(CNc2nccc3c2c(I)nn3[C@@H]2CCC[C@@H](NC(=O)OC(C)(C)C)C2)c(OC)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ PDE9A O76083 2/20 0.37
▸ TSHR P16473 2/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ USP2 O75604 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ PIK3CA P42336 1/20 0.35
▸ MTOR P42345 1/20 0.35
▸ PRKDC P78527 1/20 0.35
▸ CFTR P13569 3/20 0.35
▸ BTK Q06187 1/20 0.35
▸ ABCB1 P08183 1/20 0.35
▸ HTR3A P46098 2/20 0.35
▸ MAPT P10636 1/20 0.34
▸ CXCR4 P61073 1/20 0.34
▸ JAK2 O60674 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25228606 1.00 KMT2A (0.40) KMT2AMEN1PDE9ATSHRL3MBTL1
SCHEMBL22902838 0.94 CYP1A2 (0.38) KMT2AMEN1TSHRCYP1A2CYP3A4
SCHEMBL30449270 0.86 EGFR (0.48) BTK
SCHEMBL25284154 0.85 EGFR (0.46) BTK
SCHEMBL31125791 0.84 BTK (0.41) KMT2APDE9ATSHRBTKMAPT
SCHEMBL25649309 0.84 BTK (0.41) KMT2APDE9ATSHRBTKMAPT
SCHEMBL21903703 0.84 CYP1A2 (0.38) KMT2AMEN1PDE9ATSHRCYP1A2
SCHEMBL22902474 0.83 CYP1A2 (0.40) KMT2AMEN1TSHRCYP1A2CYP3A4
SCHEMBL24651144 0.82 NPC1 (0.43) KMT2AMEN1PDE9ATSHRCYP1A2
SCHEMBL25277694 0.82 EGFR (0.51) BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4448521-A1 REVERSIBLE MACROCYCLIC KINASE INHIBITORS Crossfire Oncology Holding B.V. (NL) 2024-10-23 — — EP disclosed
EP-4448523-A1 MACROCYCLIC BTK INHIBITORS Crossfire Oncology Holding B.V. (NL) 2024-10-23 — — EP disclosed
WO-2023110970-A1 MACROCYCLIC BTK INHIBITORS NETHERLANDS TRANSLATIONAL RESEARCH CENTER HOLDING B.V (NL) 2023-06-22 — — WO disclosed
WO-2023110936-A1 REVERSIBLE MACROCYCLIC KINASE INHIBITORS NETHERLANDS TRANSLATIONAL RESEARCH CENTER HOLDING B.V (NL) 2023-06-22 — — WO disclosed
Send feedback